Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant melanoma prognostic factors 4: ulceration width.

C L Day, R A Lew, T J Harrist

    The Journal of Dermatologic Surgery and Oncology
    |January 1, 1984
    PubMed
    Summary

    Ulceration width is a better predictor of melanoma outcomes than simply noting its presence. This measurement is poised to become the new standard for staging and prognosis in clinical stage I melanoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The RING Domain of RING Finger 12 Efficiently Builds Degradative Ubiquitin Chains.

    Journal of molecular biology·2020
    Same author

    Trends in usage of the terms keratinocyte carcinoma and nonmelanoma skin cancer in the medical literature.

    The British journal of dermatology·2019
    Same author

    Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants.

    The Journal of infectious diseases·2013
    Same author

    Observations on an outbreak of trichinosis among German prisoners of war.

    Journal of the Royal Army Medical Corps·2010
    Same author

    Early death from clinical stage I melanoma.

    The Journal of investigative dermatology·2010
    Same author

    Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.

    The Journal of investigative dermatology·2010

    Area of Science:

    • Oncology
    • Dermatology
    • Pathology

    Background:

    • Melanoma staging is crucial for patient prognosis.
    • Ulceration is a known prognostic factor in melanoma.
    • Current staging methods may not fully capture prognostic information.

    Purpose of the Study:

    • To evaluate "ulceration width" as a prognostic variable in clinical stage I melanoma.
    • To compare the prognostic value of "ulceration width" against "ulceration per se".

    Main Methods:

    • Retrospective analysis of clinical stage I melanoma patients.
    • Measurement of "ulceration width" in tumor samples.
    • Statistical analysis to determine prognostic significance.

    Main Results:

    • "Ulceration width" demonstrated superior prognostic value compared to "ulceration per se".
    • The presence or absence of ulceration alone was less informative than its measured width.

    Conclusions:

    • "Ulceration width" should replace "ulceration per se" as a prognostic indicator in clinical stage I melanoma.
    • This refined metric offers improved accuracy for predicting patient outcomes.

    Related Experiment Videos